Report: Johnson &amp; Johnson in talks to buy heart device maker ...
497700
NEW YORK -- Johnson &amp; Johnson, the New Jersey-based drug and health care products company, is reportedly in advanced negotiations to buy Guidant Corp.
405260
Johnson &amp; Johnson is picking a price fight over drug-coated stents. Does Boston Scientific Corp. need to respond?
95065
Credit Suisse First Boston maintained &quot;neutral&quot; ratings on Guidant (nyse: GDT - news - people ) and Johnson &amp; Johnson (nyse: JNJ - news - people ), saying a near-term acquisition of the former by the latter values Guidant at $76.
200948
Johnson &amp; Johnson said Wednesday night that it would acquire Indianapolis-based medical device manufacturer Guidant Corp. for $25.4 billion.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
680919
Johnson &amp; Johnson, the maker of Band- Aids and other products, is in talks to buy Guidant Corp. for more than $24 billion, the New York Times reported, citing unidentified executives familiar with the talks.
667631
The prospect of Johnson &amp; Johnson acquiring Guidant, a medical device maker that brought cutting-edge technology to cardiovascular medicine, has fueled whispers for years, gaining intensity when
546307
Johnson &amp; Johnson (nyse: JNJ - news - people ) is said to be in advanced talks to buy medical device maker Guidant (nyse: GDT - news - people ) for more than $24 billion.
160352
Health care and consumer products maker Johnson & Johnson is in negotiations to acquire medical-device maker Guidant Corp., sources familiar with the situation said on Tuesday.
505067
Johnson &amp; Johnson said on Wednesday that it will acquire device manufacturer Guidant Corp. for $25.4 billion. Under the terms of the deal announced on Wednesday, each Guidant share will be exchanged for $30.40
478171
INDIANAPOLIS - Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp., formally announced Thursday, could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
584724
Johnson &amp; Johnson (JNJ), the drug and health care products company, is reportedly in advanced negotiations to buy Guidant (GDT), a leading maker of devices to treat heart and circulatory illnesses, for more than $24 billion.
661105
US health titan Johnson and Johnson has reached a deal to acquire US heart device manufacturer Guidant Corporation, in a stock-and-cash deal valued at $23.9 billion, based on $76 a share, the companies said in a statement early this morning.
207740
Johnson &amp; Johnson (JNJ.N: Quote, Profile, Research) on Tuesday said its third-quarter profit rose almost 14 percent on higher sales of prescription drugs, but US sales of medical devices slipped on competition from a rival heart device
693727
Johnson & Johnson, the health care conglomerate, continued its acquisition talks with Guidant, one of the nation's largest makers of devices to treat heart and circulatory illnesses.
470326
Johnson &amp; Johnson said late last night it will acquire Guidant for $23.9 billion, a move that will give the big drug maker a bigger share of the explosive market for heart devices.
97019
Johnson &amp; Johnson is in advanced negotiations to acquire Guidant, an Indianapolis-based medical device maker, for more than $24 billion, executives close to the talks said Monday.